BR112014006719A2 - emplastro não aquoso - Google Patents

emplastro não aquoso

Info

Publication number
BR112014006719A2
BR112014006719A2 BR112014006719-8A BR112014006719A BR112014006719A2 BR 112014006719 A2 BR112014006719 A2 BR 112014006719A2 BR 112014006719 A BR112014006719 A BR 112014006719A BR 112014006719 A2 BR112014006719 A2 BR 112014006719A2
Authority
BR
Brazil
Prior art keywords
lidocaine
patch
dissolving agent
amount
aqueous
Prior art date
Application number
BR112014006719-8A
Other languages
English (en)
Japanese (ja)
Other versions
BR112014006719B1 (pt
Inventor
Mori Tatsuya
Yanai Yoshihiro
Saida Naoyuki
Original Assignee
Itochu Chemical Frontier Corporation
Oishi Koseido Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Itochu Chemical Frontier Corporation, Oishi Koseido Co., Ltd. filed Critical Itochu Chemical Frontier Corporation
Publication of BR112014006719A2 publication Critical patent/BR112014006719A2/pt
Publication of BR112014006719B1 publication Critical patent/BR112014006719B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)

Abstract

resumo “emplastro não aquoso”, se a lidocaína for composta de emplastro não aquoso, a força adesiva da preparação tende a ser mais baixa, conforme a quantidade de composição de lidocaína é maior. é manifesto dissolver lidocaína em um agente de dissolução, a fim de compor a lidocaína em emplastro e liberar uma quantidade eficaz na pele. no entanto, se a quantidade de agente de dissolução se tornar maior, a força adesiva se tornará extremamente baixa, de modo que uma fixação de longo prazo será difícil; um emplastro não aquoso, compreendendo lidocaína e/ou seu reagente, e um agente de dissolução contido em uma base de emplastro, o emplastro sendo mantido por um suporte do qual 50% da resistência elástica na direção longitudinal é inferior a 2.000g/50mm e composto de um tecido elástico de orientação biaxial.
BR112014006719-8A 2011-09-27 2011-09-27 Adesivo não aquoso compreendendo lidocaína BR112014006719B1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2011/072072 WO2013046335A1 (ja) 2011-09-27 2011-09-27 非水性貼付剤

Publications (2)

Publication Number Publication Date
BR112014006719A2 true BR112014006719A2 (pt) 2017-06-13
BR112014006719B1 BR112014006719B1 (pt) 2021-09-14

Family

ID=47994448

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014006719-8A BR112014006719B1 (pt) 2011-09-27 2011-09-27 Adesivo não aquoso compreendendo lidocaína

Country Status (19)

Country Link
US (2) US10765640B2 (pt)
EP (2) EP3363432B1 (pt)
JP (1) JP6021269B2 (pt)
BR (1) BR112014006719B1 (pt)
CA (1) CA2850024C (pt)
CY (1) CY1120754T1 (pt)
DK (1) DK2823815T3 (pt)
ES (2) ES2683006T3 (pt)
HR (1) HRP20181230T1 (pt)
HU (1) HUE039266T2 (pt)
LT (1) LT2823815T (pt)
MX (2) MX367430B (pt)
PL (1) PL2823815T3 (pt)
PT (1) PT2823815T (pt)
RS (1) RS57451B1 (pt)
SI (1) SI2823815T1 (pt)
TR (1) TR201810942T4 (pt)
TW (1) TW201318652A (pt)
WO (1) WO2013046335A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX349572B (es) 2011-05-10 2017-08-03 Itochu Chemical Frontier Corp Parche no acuoso.
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
US9925264B2 (en) 2011-05-10 2018-03-27 Itochu Chemical Frontier Corporation Non-aqueous patch
RS57451B1 (sr) 2011-09-27 2018-09-28 Itochu Chemical Frontier Corp Ne-vodena obloga
BR112018003617A2 (pt) * 2015-08-24 2018-12-11 Itochu Chemical Frontier Corp adesivo não aquoso compreendendo lidocaína e método para administrar referido adesivo
WO2018052039A1 (ja) * 2016-09-16 2018-03-22 ニチバン株式会社 貼付剤
JP6290521B1 (ja) * 2016-09-16 2018-03-07 ニチバン株式会社 貼付剤
EP3960238A4 (en) * 2019-04-24 2023-01-25 MEDRx Co., Ltd. LIDOCAINE PATCH
JP7179212B1 (ja) 2022-05-02 2022-11-28 久光製薬株式会社 リドカイン含有貼付剤
WO2023225143A1 (en) * 2022-05-19 2023-11-23 Tpc-Api Llc Highly elastic patches and masks for delivery of therapeutic agents

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE451669C (sv) 1984-02-17 1989-08-14 Moelnlycke Ab Kompress innehaallande zinkoxid
IL86170A (en) 1987-05-01 1992-12-01 Elan Transdermal Ltd Preparations and compositions comprising nicotine for percutaneous administration
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5656286A (en) 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
EP0387751B1 (en) 1989-03-15 1994-06-08 Nitto Denko Corporation Medicated plasters
US5411738A (en) 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
CA1338779C (en) 1989-03-17 1996-12-10 Harry Hind Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics
US5098417A (en) 1990-04-12 1992-03-24 Ricoh Kyosan, Inc. Cellulosic wound dressing with an active agent ionically absorbed thereon
JP3115625B2 (ja) 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
JP2816765B2 (ja) 1991-08-30 1998-10-27 久光製薬株式会社 消炎鎮痛貼付剤
US5804213A (en) 1991-10-09 1998-09-08 Lectec Corporation Biologically active aqueous gel wound dressing
DE4224325C1 (de) 1992-07-23 1994-02-10 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster für niedrigschmelzende und/oder flüchtige Wirkstoffe und Verfahren zu seiner Herstellung
US6056738A (en) 1997-01-31 2000-05-02 Transmedica International, Inc. Interstitial fluid monitoring
JPH07215850A (ja) 1994-02-04 1995-08-15 Sekisui Chem Co Ltd 局所麻酔用経皮吸収テープ
US5536263A (en) 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
IL113034A (en) 1994-04-05 2000-02-17 Astra Ab Topical dressing
US5618274A (en) 1994-04-08 1997-04-08 Rosenthal; Kenneth J. Method and device for deep pressurized topical, fornix applied "nerve block" anesthesia
SE9401620L (sv) 1994-05-10 1996-01-10 Alpharma Ab Kombinerad användning av lokalbedövningsmedel och täckande förband
US5601839A (en) 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US6245347B1 (en) 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US6461644B1 (en) 1996-03-25 2002-10-08 Richard R. Jackson Anesthetizing plastics, drug delivery plastics, and related medical products, systems and methods
FR2748207B1 (fr) 1996-05-06 1998-06-12 Cird Galderma Composition a base d'un compose modulant la reactivite des fibres nerveuses
JPH09315964A (ja) * 1996-05-27 1997-12-09 Chinhin Boku 肩こり・五十肩治療用貼付剤
CA2259418A1 (en) 1996-07-11 1998-01-22 Farmarc Nederland B.V. Pharmaceutical composition containing acid addition salt of basic drug
US5985317A (en) 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
US6365178B1 (en) 1996-09-06 2002-04-02 Watson Pharmaceuticals, Inc. Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions
JPH10147521A (ja) * 1996-09-18 1998-06-02 Yuutoku Yakuhin Kogyo Kk 持続性疼痛緩和用貼付剤
WO1998014184A1 (fr) 1996-10-04 1998-04-09 Saitama Daiichi Seiyaku Kabushiki Kaisha Timbre percutane
JPH1149670A (ja) 1997-08-04 1999-02-23 Nichiban Co Ltd 局所麻酔用経皮吸収型製剤
US5891919A (en) 1997-09-19 1999-04-06 Burlington Bio-Medical & Scientific Corp. Denatonium capsaicinate and methods of producing the same
NZ504108A (en) 1997-09-26 2002-06-28 Noven Pharma Bioadhesive compositions comprising a polyvinylpyrrolidone polymer and methods for topical administration of active agents
FR2770843B1 (fr) 1997-11-13 2000-01-14 Lavipharm Lab Association prolamines-lipides polaires vegetaux, son procede de preparation et ses applications
US6120792A (en) 1998-04-29 2000-09-19 Juni; Jack E. Medicated skin patch and method for its use
US6264927B1 (en) 1998-08-27 2001-07-24 Elmer P. Monahan Topical solution and method for the treatment of nail fungus
JP3159688B2 (ja) 1998-10-05 2001-04-23 祐徳薬品工業株式会社 経皮吸収テープ剤
WO2000019986A1 (fr) 1998-10-05 2000-04-13 Yutoku Pharmaceutical Ind. Co. Ltd. Bande pour absorption percutanee
US7127285B2 (en) 1999-03-12 2006-10-24 Transport Pharmaceuticals Inc. Systems and methods for electrokinetic delivery of a substance
US6689380B1 (en) 1999-05-17 2004-02-10 Kevin S. Marchitto Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
US6299902B1 (en) 1999-05-19 2001-10-09 The University Of Georgia Research Foundation, Inc. Enhanced transdermal anesthesia of local anesthetic agents
DE19923906A1 (de) 1999-05-26 2000-11-30 Basf Ag Optisch transparenter polymerer Festelektrolyt
US6580011B1 (en) 1999-07-29 2003-06-17 Barbara Jennings-Spring Circumcision/penile dressing
US6528086B2 (en) 1999-09-28 2003-03-04 Zars, Inc. Methods and apparatus for drug delivery involving phase changing formulations
US6383511B1 (en) 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
US6264981B1 (en) 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
AU4842100A (en) 1999-12-10 2001-06-18 Teri Buseman Anti pruritic patch
ATE353636T1 (de) * 1999-12-15 2007-03-15 Hisamitsu Pharmaceutical Co Adhäsive zubereitungen
US6455066B1 (en) 2000-03-10 2002-09-24 Epicept Corporation Intradermal-penetration agents for topical local anesthetic administration
JP2001302501A (ja) * 2000-04-17 2001-10-31 Oishi Koseido:Kk 肩こり・膝関節痛・五十肩等の治療用貼付剤
EP1276475A2 (en) 2000-04-28 2003-01-22 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
AU2001264256B2 (en) 2000-06-13 2006-05-11 Hisamitsu Pharmaceutical Co, Inc Plaster
GB0015617D0 (en) 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
JP4787397B2 (ja) * 2000-08-28 2011-10-05 日東電工株式会社 粘着剤組成物および粘着テープもしくはシート
US7288265B1 (en) 2000-10-16 2007-10-30 Lectec Corporation Treating viral infection at smallpox vaccination site
US20020106402A1 (en) * 2000-12-05 2002-08-08 Hartwig Rod Lawson Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use
US6830758B2 (en) 2001-04-02 2004-12-14 Lectec Corporation Psoriasis patch
US7094228B2 (en) 2001-07-31 2006-08-22 Zars, Inc. Methods and formulations for photodynamic therapy
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
JP2003137773A (ja) * 2001-10-31 2003-05-14 Hisamitsu Pharmaceut Co Inc 積層支持体を有する貼付剤
TWI312885B (en) 2001-12-06 2009-08-01 Nec Lcd Technologies Ltd Semi-transmissive liquid crystal display device
GB2382778B (en) 2001-12-07 2005-02-16 Blatchford & Sons Ltd An orthotic strut component
US7921999B1 (en) 2001-12-20 2011-04-12 Watson Laboratories, Inc. Peelable pouch for transdermal patch and method for packaging
JP2003191659A (ja) 2001-12-25 2003-07-09 Fuji Photo Film Co Ltd 平版印刷版用アルミニウム支持体とその製造方法、および平版印刷原版
JP4206342B2 (ja) 2002-02-19 2009-01-07 久光製薬株式会社 経皮吸収型貼付剤
JP4792193B2 (ja) * 2002-08-28 2011-10-12 久光製薬株式会社 貼付剤
US7166641B2 (en) 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
US20040076671A1 (en) 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
DE10260873A1 (de) 2002-12-23 2004-07-15 Beiersdorf Ag Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin
US7993654B2 (en) 2002-12-23 2011-08-09 Beiersdorf Ag Self-adhesive polymer matrix containing sea algae extract
ES2531326T3 (es) 2003-02-28 2015-03-13 Biointeractions Ltd Sistemas de red polimérica para dispositivos médicos y métodos de uso
US7179477B2 (en) 2003-08-15 2007-02-20 Shyam K Gupta Cosmetic dermabrasion treatment system
US6998109B1 (en) 2004-01-07 2006-02-14 Pearson Research & Development Limited Emu-based formulations with lidocaine for wound treatment by inhibiting microbial activity
WO2005072775A1 (ja) 2004-01-29 2005-08-11 Medrx Co., Ltd. 消炎鎮痛外用剤
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
WO2006017632A1 (en) * 2004-08-04 2006-02-16 Cassel Douglas R An analgesic patch for sports injury and rehabilitation medicine and method to alleviate pain
WO2006044206A2 (en) 2004-10-08 2006-04-27 Noven Pharmaceuticals, Inc. Transdermal drug delivery device including an occlusive backing
AU2006326018B2 (en) 2005-12-14 2013-04-18 Nuvo Research Inc. Compositions and methods for dermally treating pain
JP5037831B2 (ja) * 2006-02-15 2012-10-03 久光製薬株式会社 凝集力向上及び徐放化の外用貼付剤
CN101404992A (zh) 2006-02-17 2009-04-08 N·D·扎斯勒 局麻药用于调节神经源性震颤的新用途
US7910135B2 (en) 2006-10-13 2011-03-22 Uluru Inc. Hydrogel wound dressing and biomaterials formed in situ and their uses
US20100003313A1 (en) 2006-10-27 2010-01-07 Hisamitsu Pharmaceutical Co.,Inc. Adhesive skin patch
US7904146B2 (en) 2006-11-13 2011-03-08 Travanti Pharma Inc. Transdermal systems for the delivery of ionic agents directly to open wounds and surgically repaired incisions
US8236417B2 (en) * 2006-12-01 2012-08-07 Kuraray Co., Ltd. Pressure-sensitive adhesive for optical films
US20100029704A1 (en) 2007-01-29 2010-02-04 Medrx Co., Ltd. Salt of nonsteroidal anti-inflammatory drug and organic amine compound and use thereof
US8722065B2 (en) 2007-11-11 2014-05-13 Medrx Co., Ltd. Lidocaine tape preparation
JP5130026B2 (ja) * 2007-11-16 2013-01-30 日東電工株式会社 貼付剤および貼付製剤
US8827966B2 (en) * 2008-04-30 2014-09-09 Soukenbi Corporation Skin patch instrument for treating pain
US20090297591A1 (en) 2008-05-30 2009-12-03 Orient Pharma Co., Ltd. Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds
US8231906B2 (en) 2008-07-10 2012-07-31 Noven Pharmaceuticals, Inc. Transdermal estrogen device and delivery
JP5544544B2 (ja) 2008-08-05 2014-07-09 株式会社 メドレックス 塩基性薬効成分の脂肪酸塩、安息香酸塩を含有する外用剤とその製造方法
US20100092544A1 (en) 2008-10-14 2010-04-15 Katsuhiro Okada Adhesive composition for patch and use thereof
US8815261B2 (en) 2009-06-19 2014-08-26 Medrx Co., Ltd. Composition for external application comprising aripiprazole and organic acid as active ingredients
ES2688658T3 (es) 2009-07-24 2018-11-06 Teikoku Seiyaku Co., Ltd. Preparación adhesiva que contiene fentanilo para uso externo
KR101070864B1 (ko) 2009-12-11 2011-10-10 김성한 광학식 터치스크린
TWI482645B (zh) 2010-01-07 2015-05-01 Teikoku Seiyaku Kk 含有待克菲那（ｄｉｃｌｏｆｅｎａｃ）羥乙基吡咯啶之外用油性敷貼劑
MX349572B (es) 2011-05-10 2017-08-03 Itochu Chemical Frontier Corp Parche no acuoso.
US9925264B2 (en) 2011-05-10 2018-03-27 Itochu Chemical Frontier Corporation Non-aqueous patch
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
RS57451B1 (sr) 2011-09-27 2018-09-28 Itochu Chemical Frontier Corp Ne-vodena obloga
BR112018003617A2 (pt) 2015-08-24 2018-12-11 Itochu Chemical Frontier Corp adesivo não aquoso compreendendo lidocaína e método para administrar referido adesivo
WO2019220420A1 (en) 2018-05-18 2019-11-21 Pedranti William Non-aqueous patch with superior adhesion characteristics

Also Published As

Publication number Publication date
SI2823815T1 (sl) 2018-09-28
BR112014006719B1 (pt) 2021-09-14
PT2823815T (pt) 2018-10-22
DK2823815T3 (en) 2018-08-06
PL2823815T3 (pl) 2018-10-31
EP2823815A4 (en) 2015-10-14
US20140356412A1 (en) 2014-12-04
US11793766B2 (en) 2023-10-24
CY1120754T1 (el) 2019-12-11
LT2823815T (lt) 2018-08-27
RS57451B1 (sr) 2018-09-28
CA2850024A1 (en) 2013-04-04
TR201810942T4 (tr) 2018-09-21
JPWO2013046335A1 (ja) 2015-03-26
EP3363432B1 (en) 2020-12-23
ES2683006T3 (es) 2018-09-24
JP6021269B2 (ja) 2016-11-09
HRP20181230T1 (hr) 2018-10-05
US10765640B2 (en) 2020-09-08
MX352752B (es) 2017-12-06
ES2845524T3 (es) 2021-07-27
EP2823815A1 (en) 2015-01-14
US20210038531A1 (en) 2021-02-11
MX367430B (es) 2019-07-11
CA2850024C (en) 2020-07-07
TW201318652A (zh) 2013-05-16
EP2823815B1 (en) 2018-07-04
HUE039266T2 (hu) 2018-12-28
EP3363432A1 (en) 2018-08-22
WO2013046335A1 (ja) 2013-04-04
MX2014003688A (es) 2014-07-28

Similar Documents

Publication Publication Date Title
BR112014006719A2 (pt) emplastro não aquoso
BR112022002892A2 (pt) Trombossomos como um agente de reversão de agente antiplaqueta
CL2016000950A1 (es) Composición farmacéutica acuosa que comprende insulina glulisina y metionina; kit farmacéutico; uso en el tratamiento de la diabetes tipo 1 ó 2.
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
CR20150523A (es) Uso de 2,3-dihidroimidazo [1,2-c]quinazolinas sustituidas
BR112015023648A2 (pt) revestimento de superfície reativo com propriedades de descontaminação química e biocidas
BR112016020584A2 (pt) Composições de peptídeo auto-organizável
CL2017002082A1 (es) Nuevas proteínas especificas para pioverdina y pioquelina
BR112015006426A2 (pt) composições nutricionais que incluem beta-hidróxi-beta-metilbutirato de cálcio, proteína e baixos níveis de eletrólitos
BR112012027633A2 (pt) processo para fabricar material estruturado, uso de géis de celulose nanofibrilares, e, material estruturado
BR112016014247A2 (pt) Composição aquosa esterilizada, processos de fabricação da mesma, de obtenção de uma composição aquosa esterilizada de ácido hialurônico, utilizações de mepivacaína, e de uma composição aquosa esterilizada, kit, e, processo para melhorar a resistência à degradação das propriedades reológicas de uma composição aquosa injetável de ácido hialurônico
AR089228A1 (es) Rendimiento dirigido de las composiciones de hipohalito, sus metodos y sistemas
PE20160048A1 (es) Composiciones antibioticas de ceftolozano
CL2015002433A1 (es) Imidazopiridazinas sustituidas
BR112014031701A2 (pt) composição para a preparação de um emplastro não aquoso
BR112016003356A8 (pt) composição para aperfeiçoamento da saúde do sistema respiratório e aumento da concentração de íons hipotiocianato em pulmões de vertebrados e seu uso
DOP2012000111A (es) Celulosa microfibrosa con una distribucion del tamaño de las particulas que le permite ser utilizada en composiciones surfactantes estructuradas
AR081227A1 (es) Preparaciones basadas en fibrinogenos y polisacaridos sulfatados
BR112016013324A8 (pt) cimento substituto de enxerto de osso e composição de partículas adaptada para formação do mesmo
BR112017012978A2 (pt) composições adjuvantes aquosas contendo eletrólitos, composições contendo substância ativa e o uso das mesmas
BR112016007487A2 (pt) composições compreendendo citrulina e leucina e seu uso no tratamento de diabetes e de síndrome meta-bólica
PE20160861A1 (es) Soluciones para incrementar la estabilidad y la vida util de un organo, y solucion de conservacion de tejido
BR112016024603A2 (pt) composições de protetor solar
BR112017013084A2 (pt) composições de polietileno com propriedades ópticas melhoradas
BR102015012091A8 (pt) método para a preparação de uma solução de albumina humana, e, composição

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/09/2011, OBSERVADAS AS CONDICOES LEGAIS.